A pioneer in the field of cardiovascular biology, Michael Simons serves as the founder of the Yale Cardiovascular Research Center and as the Robert W. Berliner Professor of Medicine and Cell Biology at the Yale School of Medicine. Over the years, Michael Simons has earned numerous awards for his work and was named a pilot grant finalist for the 2017 Blavatnik Fund for Innovation at Yale.
Available to Yale faculty, the Blavatnik Fund for Innovation supports innovative research in the life sciences sector. The fund was created to help faculty members obtain funding for their early-stage validation and proof-of-concept studies. Through the fund, faculty members can receive business development and financial support as they attempt to validate and advance nascent technologies.
Supporting research projects of all sizes, Blavatnik Fund grants are divided into two sections: pilot grants and development grants. Up to $100,000 is awarded in a pilot grant, while up to $300,000 may be given in a development grant.
